Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Davis

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|September 27, 2003
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectDavid R Nelson, Zhengkun Tu, Consuelo Soldevila-Pico, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2006
Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formulaRichard B Freeman, Robert G Gish, Ann Harper, et al.
Proceedings (Baylor University. Medical Center)|July 17, 2008
Hepatocellular carcinoma: management of an increasingly common problemGary L Davis, Jane Dempster, James D Meler, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 6, 2004
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis CManal F Abdelmalek, Roberto J Firpi, Consuelo Soldevila-Pico, et al.
Gastroenterology|October 22, 2013
Hepatitis C screening: summary of recommendations from the clinical decision tool, Mark D Boldt, Joel V Brill, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Economic model of a birth cohort screening program for hepatitis C virusLisa J McGarry, Vivek S Pawar, Hemangi R Panchmatia, et al.
Gastroenterology|July 2, 2008
Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitisMansour A Parsi, Sherif N Saadeh, Nizar N Zein, et al.
Clinical Transplantation|January 29, 2013
Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantationPeter T W Kim, Nicholas Onaca, Srinath Chinnakotla, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2006
An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD scoreNicholas Onaca, Marlon F Levy, Takehisa Ueno, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2008
Hepatitis C virus: a critical appraisal of approaches to therapyDavid R Nelson, Gary L Davis, Ira Jacobson, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|September 27, 2003
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectDavid R Nelson, Zhengkun Tu, Consuelo Soldevila-Pico, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2006
Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formulaRichard B Freeman, Robert G Gish, Ann Harper, et al.
Proceedings (Baylor University. Medical Center)|July 17, 2008
Hepatocellular carcinoma: management of an increasingly common problemGary L Davis, Jane Dempster, James D Meler, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 6, 2004
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis CManal F Abdelmalek, Roberto J Firpi, Consuelo Soldevila-Pico, et al.
Gastroenterology|October 22, 2013
Hepatitis C screening: summary of recommendations from the clinical decision tool, Mark D Boldt, Joel V Brill, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Economic model of a birth cohort screening program for hepatitis C virusLisa J McGarry, Vivek S Pawar, Hemangi R Panchmatia, et al.
Gastroenterology|July 2, 2008
Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitisMansour A Parsi, Sherif N Saadeh, Nizar N Zein, et al.
Clinical Transplantation|January 29, 2013
Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantationPeter T W Kim, Nicholas Onaca, Srinath Chinnakotla, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2006
An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD scoreNicholas Onaca, Marlon F Levy, Takehisa Ueno, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2008
Hepatitis C virus: a critical appraisal of approaches to therapyDavid R Nelson, Gary L Davis, Ira Jacobson, et al.
Pageof 7